Connect with us

News

Experts Welcome ICMR’s Move To Remove Plasma Therapy As COVID-19 Treatment

The recent view on discontinuing the use of plasma therapy comes a day after a meeting of ICMR-National Task Force for COVID-19 was held during which its ‘ ineffectiveness’ in a number of cases was discussed

Experts Welcome ICMR’s Move To Remove Plasma Therapy As COVID-19 Treatment
Highlights
  • Plasma therapy was being used as one of the treatments for COVID-19
  • Plasma therapy has failed to change the course of mortality: Dr DS Rana
  • ICMR had earlier also advised against indiscriminate use of plasma therapy

New Delhi: Several top medical experts have welcomed the Indian Council of Medical Research (ICMR)’s updated advisory released on Monday (May 17) dropping the use of convalescent plasma from recommended treatment protocols for COVID-19. Sir Ganga Ram Hospital chairman Dr DS Rana said plasma therapy has failed to change the “course of mortality” and asserted that some scientists are also of the view that it is helping in promoting mutations and variants. “I think it is wise that plasma therapy has been taken off the list because over a period of one year it has failed to change the course of mortality. Every step taken should absolutely be based on the evidence. Some scientists are also of the view that this is helping in promoting mutations and variants,” he added.

Also Read: Convalescent Plasma Therapy Didn’t Help In Reducing COVID-19 Deaths: ICMR Study

With an exponential rise in COVID-19 cases across the country, there has been an unprecedented spur in the demand for plasma which many experts believe to have done more harm than good. Dr Sheeba Marwah, Assistant Professor and COVID-19 Nodal Officer, Department of Obstetrics and Gynaecology Vardhman Mahavir Medical College and Safdarjung Hospital said:

The current research being done globally using convalescent plasma of patients recovered from COVID-19 for treatment of new COVID-19 patients have not yielded any efficacious results when it comes to modifying the disease course or thwarting its progression to severe disease and averting mortality. Even the ICMR’s PLACID Trial concluded convalescent plasma therapy to be non-beneficial.

Also Read: Bleeding, Clotting Cases After Covishield Jab “Minuscule”: Centre’s Panel

Dr Marwah stated that on the contrary, “possibilities of more virulent strains having surfaced due to its irrational use are very much there, so it’s a good decision to remove it from the national protocol.” Earlier, as per the ICMR advisory on April 22, Convalescent plasma (Off label) was considered only when the following criteria were met: Early moderate disease (preferably within 7 days of symptom onset, no use after 7 days) and Availability of high titre donor plasma (Signal to the cut-off ratio (S/O) >3.5 or equivalent depending on the test kit being used).

Also Read: Prevention Of Fungal Infections Key Area Of Focus In Treating COVID Patients: AIIMS Director

As per the previous advisory, Remdesivir, Tocilizumab (off label) and Convalescent plasma (Off label) were used for the treatment of COVID-19 patients. However, the latest advisory mentions that only Remdesivir, Tocilizumab (off label) can be used. The recent view on discontinuing the use of plasma therapy comes a day after a meeting of ICMR-National Task Force for COVID-19 was held during which its ‘ ineffectiveness’ in a number of cases was discussed.

As India’s daily spike of coronavirus cases witnesses, a dip with only 2,63,533 fresh infections recorded in the last 24 hours, the number of deaths due to COVID-19 continues to remain alarmingly high with 4,329 more fatalities, the highest toll in a single day since the pandemic began. According to the Union Health Ministry, the country also saw a massive jump in the number of recoveries with 4,22,436 fresh discharges. The cumulative caseload stands at 2,52,28,996, including 2,15,96,512 recoveries, 33,53,765 active cases and 2,78,719 deaths.

Also Read: Vaccines ‘Almost Certainly Less Effective’ Against B1.617.2 Transmission: UK Expert

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Folk Music For A Swasth India

RajasthanDay” src=

Reckitt’s Commitment To A Better Future

Expert Blog

हिंदी में पड़े

Latest Posts